Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) for the Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) and Cocaine Dependence

NCT00553319 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT00553319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00553319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) for the Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) and Cocaine Dependence
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2007
Completion date
July 31, 2013
Enrollment
139 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adult attention deficit hyperactivity disorder, cocaine dependence